Literature DB >> 1317496

Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels.

M K Sutherland1, M J Somerville, L K Yoong, C Bergeron, M R Haussler, D R McLachlan.   

Abstract

Receptors for vitamin D hormone (VDR) and the calcium binding protein, calbindin-28k, have been localized in many tissues, including brain. In brain, VDR and calbindin-28k were reported to colocalize in hippocampal CA1 cells. We have shown that mRNA pool size for calbindin-28k was reduced, on average, by 35% in Alzheimer hippocampal CA1 cells, as compared to Huntington control (manuscript in preparation). In the present study, in situ hybridization with tritiated antisense RNA probes was used to examine VDR expression in paired Alzheimer and Huntington brain tissue. Message levels for VDR were reduced, on average, by 34% and 31%, respectively, in Alzheimer hippocampal CA1 and CA2 pyramidal cells, as compared to Huntington control. However, VDR message levels were not significantly different from control in Alzheimer temporal cortex or cerebellum. There was no correlation between VDR message levels and brain weight, autopsy interval, patient age or the extent of neurofibrillary degeneration. Instead, VDR mRNA pool size in hippocampal CA1 cells correlated significantly with calbindin-28k message levels (r = 0.52, P less than 0.001). Decreased message levels for VDR and calbindin-28k in these cells were due to an increased percentage of cells expressing lower message levels for these proteins. These results show that in Alzheimer hippocampal CA1 cells, VDR mRNA pool size is downregulated and that this downregulation may play a role in the reduction of calbindin-28k expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317496     DOI: 10.1016/0169-328x(92)90032-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  46 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 2.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.

Authors:  Michael J Berridge
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

3.  Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice.

Authors:  Louise Bennett; Cindy Kersaitis; Stuart Lance Macaulay; Gerald Münch; Garry Niedermayer; Julie Nigro; Matthew Payne; Paul Sheean; Pascal Vallotton; Dimitrios Zabaras; Michael Bird
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Authors:  Erdinç Dursun; Esin Candaş; Selma Yılmazer; Duygu Gezen-Ak
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

5.  Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the Health, Aging and Body Composition Study.

Authors:  Valerie K Wilson; Denise K Houston; Laurel Kilpatrick; James Lovato; Kristine Yaffe; Jane A Cauley; Tamara B Harris; Eleanor M Simonsick; Hilsa N Ayonayon; Stephen B Kritchevsky; Kaycee M Sink
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

6.  The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.

Authors:  Duygu Gezen-Ak; İrem L Atasoy; Esin Candaş; Merve Alaylıoğlu; Erdinç Dursun
Journal:  Neuromolecular Med       Date:  2018-06-12       Impact factor: 3.843

7.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 8.  More than healthy bones: a review of vitamin D in muscle health.

Authors:  S Bobo Tanner; Susan A Harwell
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

Review 9.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 10.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.